Why kidney cancer diagnosis is hard
Renal tumors — benign versus malignant, and across several histologic subtypes — differ only subtly on CT imaging. This creates inter-observer variability even among radiologists, and can lead to unnecessary biopsies or surgery.
How ARNA-Renal approaches it
ARNA-Renal takes multi-phase abdominal CT as input and performs the following in one unified pipeline:
- Detection and segmentation of kidney and tumor regions
- Differential diagnosis across five major histologic subtypes
- Quantitative information to support surgical planning
The technology is grounded in research published in top-authority journals including Nature Oncology, IEEE, and CIBM. On independent validation datasets it achieved diagnostic performance comparable to — or better than — radiologists.
What it means in practice
The point is not to replace physicians, but to help them make faster, more consistent decisions. ARNA-Renal is designed to support clinicians throughout the entire process from diagnosis to surgery.
Learn more on the product page.